Frey A W, Haider M, Rösch A, Rösch R, Drummer C, Gerzer R, Theisen K
Medizinische Klinik, Klinikum Innenstadt der Universität München.
Z Kardiol. 1991;80 Suppl 5:55-7.
In the present study, we took whole blood from 12 patients treated with heparin, acetylsalicylic acid, and nitroglycerin i.v., to measure the aggregability of platelets after acute and prolonged i.v. application of nitroglycerin and after oral application of molsidomine. Aggregation was induced by platelet-activating-factor (PAF). As a measure for platelet aggregability, we determined the PAF-concentration needed to induce irreversible aggregation (threshold dose) and the maximum slope of the aggregation curve with 50 nM PAF. At the beginning, 1 h after the onset of nitroglycerin infusion (3 mg/h), 24 h and 1 h after increasing the nitroglycerin dose (5 mg/h), neither the maximum slope nor the threshold dose for PAF-induced aggregation differed significantly. However, after additional oral application of molsidomine the maximum slope of the aggregation curve decreased significantly. These data indicate that molsidomine decreases the aggregability of platelets in patients, even after pretreatment with heparin, acetylsalicylic acid, and nitroglycerin.
在本研究中,我们采集了12例接受肝素、乙酰水杨酸和静脉注射硝酸甘油治疗的患者的全血,以测量急性和长时间静脉注射硝酸甘油后以及口服吗多明后血小板的聚集性。血小板聚集由血小板激活因子(PAF)诱导。作为血小板聚集性的指标,我们测定了诱导不可逆聚集所需的PAF浓度(阈剂量)以及50 nM PAF时聚集曲线的最大斜率。开始时、硝酸甘油输注(3 mg/h)开始后1小时、增加硝酸甘油剂量(5 mg/h)后24小时和1小时,PAF诱导聚集的最大斜率和阈剂量均无显著差异。然而,在额外口服吗多明后,聚集曲线的最大斜率显著降低。这些数据表明,即使在肝素、乙酰水杨酸和硝酸甘油预处理后,吗多明仍可降低患者血小板的聚集性。